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Familial adenomatous polyposis (FAP) is an autosomal dominant
inherited disease due to mutations in the tumour suppressor adeno-
matous polyposis coli (APC) gene (Bodmer et al, 1987; Groden et
al, 1991; Kinzler et al, 1991). FAP is characterized by the develop-
ment of multiple adenomatous polyps throughout the large intes-
tine (Haggitt et al, 1986; Utsunomiya, 1989) and is associated with
a very high risk of colorectal cancer and with a variety of extra-
colorectal disease manifestations (Jones et al, 1986; Jagelman,
1987; Baker et al, 1988; Morton et al, 1992; Olschwang et al,
1993; Caspari et al, 1995; Valanzano et al, 1996). The APC gene is
comprised of 15 exons, of which exon 15 encodes for more than
50% of the protein (Groden et al, 1991; Kinzler et al, 1991). The
APC protein is composed of 2843 amino acids and mediates
growth regulatory signals by its association with the microtubule
cytoskeleton and with the cadherin-binding protein b-catenin.
Amino-terminal residues 1–171 are implicated in homodimeriza-
tion, being the first 55 amino acids sufficient to form a stable
dimer (Joslyn et al, 1993). Amino-terminal residues 453–767
contain seven copies of a repeating 42 amino acids motif, origi-
nally identified in the Drosophila segment polarity gene product
armadillo, a component of the wingless transduction pathway
(Peifer et al, 1994). Furthermore, the APC protein binds b-catenin
through two motifs: the first, located between residues 1020–1169,
which contains three 15 amino acid repeats (Rubinfeld et al, 1993;
Su et al, 1993); the second, located between residues 1342–2075,
which comprises 7 repeats of 20 amino acids (Rubilfeld et al,
1997). This second motif acts also as substrate for serine-threonine
glycogen synthase kinase-3b (GSK-3b) association and phospho-
rylation (Rubinfeld et al, 1996). The large body of data collected
on APC mutations in FAP has contributed to establish correlations
between type and location of the mutation and clinicopathologic
features of the disease. There is a wide variability in the clinical
presentation of FAP, in terms of age at disease onset and number
and distribution of colorectal adenomatous polyps (Giardiello et
al, 1994; Presciuttini et al, 1994). Certain phenotypic characteris-
tics of FAP appear to be correlated with the site of APC mutations
(Spirio et al, 1993; Caspari et al, 1994; Gayther et al, 1994; Friedl
et al, 1996; Soravia et al, 1998). Mutations at the very 5¢ end
(codons 1–157) and towards the 3¢ end of the gene (i.e. beyond
codon 1578) are associated with a form of FAP characterized by
relatively low numbers of colorectal adenomatous polyps (5–100)
and comparatively late disease onset, designated attenuated adeno-
matous polyposis coli (AAPC) (Leppert et al, 1990; Friedl et al,
1996; Soravia et al, 1998). Furthermore, we and others described
attenuated forms of FAP in kindreds with germline mutations in
regions of the APC gene that are subjected to alternative splicing
(Curia et al, 1998). On the contrary, the most frequent APC
germline mutation, localized at codon 1309, is associated with a
very severe form of FAP, characterized by hundreds to thousands
colorectal adenomas and early onset (Caspari et al, 1994; Gayther
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1309 APC gene mutation die on the average 10 years earlier than
FAP patients with germline mutations at sites other than codon
1309 (Caspari et al, 1994; Gayther et al, 1994). Interestingly,
codon 1309 lies within the ‘mutation cluster region’ (codons
1286–1514), i.e. the region of the APC gene that exhibits a definite
accumulation of somatic mutations in both FAP-associated and
non-FAP-associated colorectal tumours (Miyoshi et al, 1992;
Miyaki et al, 1994; Yashima et al, 1994).
In spite of a number of important studies that documented the
genetic bases of phenotypic heterogeneity in FAP (Leppert et al,
1990; Morton et al, 1992; Caspari et al, 1994; Gayther et al, 1994;
Giardiello et al, 1994; Friedl et al, 1996; Soravia et al, 1998), there
is a scarcity of data concerning correlations between number of
colorectal adenomas, as evaluated by direct count on colectomy
specimens, and position of the germline APC gene mutation
responsible for the disease. The present study correlates colorectal
disease manifestations with the results of APC mutational analysis
in 29 colectomized FAP patients from 21 unrelated kindreds.
MATERIALS AND METHODS
Patients
Twenty-nine FAP patients from 21 unrelated kindreds were
enroled in the study. All patients were treated with colectomy. The
age at colectomy depended solely on the extent of the disease
progression and ranged from 10 to 62 years (average 24.7). For
each case, the area of mucosal surface of each colorectal segment
(right, transverse and left colon, sigma and rectum), as well as the
total area of colorectal mucosal surface, were obtained based on
measurements taken on fresh colectomy specimens. The number
of adenomas in the right, transverse and left colon, sigma and
rectum was determined after the careful count of polyps visible on
the mucosal surface of the fresh colectomy specimen and
randomly confirmed by microscopic examinations. The density of
adenomas per 4 cm2 unit area of mucosal surface was calculated
by dividing the number of adenomas determined in each anatom-
ical segment, or in the entire colorectum, by the respective area of
mucosal surface, expressed in cm2. In kindred GD-11, because of
the profuse adenomatosis, the number of adenomas was extra-
polated by counts limited to representative 4 cm2 unit areas of
mucosal surface for each anatomical segment of the colorectum.
Mutational analysis of the APC gene
Mutational analysis of the APC gene was conducted after full
informed consent, using genomic DNA and/or total RNA
extracted from fresh peripheral blood lymphocytes. Genetic
analyses were always confirmed using DNA deriving from two
independent blood samples and were performed employing a
combination of three screening strategies, followed by direct
sequencing (Cama et al, 1991). Heteroduplex analysis on agarose
minigel (HAAM), coupled with allele-specific multiplex PCR,
was designed to rapidly identify the three frequently occurring
deletions of the APC gene at codons 1061, 1068 and 1309 (Cama
et al, 1995). Single-strand conformation polymorphism (SSCP)
analysis was used to screen the coding sequence of the APC gene
spanning exons 1 through 14 (Groden et al, 1991, 1993; Cama et
al, 1994). The in vitro synthesized protein (IVSP) assay was used
for the rapid identification of truncating mutations in exon 15 (van
der Luijt et al, 1994; Valanzano et al, 1996). Primers used for
amplifications were as reported elsewhere (Groden et al, 1991,
1993; Miyoshi et al, 1992; van der Luijt et al, 1994). The research
protocol was approved by the ethical review board of the
University Gabriele D’Annunzio.
Statistical analysis
The total number of adenomas at colectomy, the density of
adenomas per unit area of mucosal surface obtained for the entire
colorectum and for each colorectal anatomical segment were
correlated with age at colectomy and with site of APC mutation.
Statistical evaluations were performed using the analysis of
variance (ANOVA-test). Probability values (P-values) of less than
0.05 were considered significant.
RESULTS
The combined use of the HAAM, SSCP and IVSP assays for muta-
tional analysis allowed the detection of 15 different germline APC
mutations responsible for disease in 29 FAP patients from 21 unre-
lated kindreds (Table 1 and Figure 1). Ten mutations were clus-
tered at the 5¢ end of exon 15, between codons 876 and 1556. Five
mutations were respectively located within exons 5 (codon 208), 6
(codon 232), 9 (codons 367 and 437), and 14 (codon 623). With
the exception of the novel mis-sense mutation at codon 208, all
other mutations are predicted to introduce premature termination
signals. The mutation at codon 1324 determines a frame-shift
introducing a distant stop signal 90 codons downstream. The mis-
sense mutation at codon 208 is considered pathogenic on the basis
of its co-segregation with 3 FAP patients in the kindred (informa-
tion kindly supplied by Dr L Varesco, Istituto Nazionale Ricerca
Cancro, Genova, Italy and confirmed in our laboratory) and lack of
segregation in unaffected members of the family. This APC allelic
variant is unlikely to be a common polymorphism as it has not
been detected in additional 118 chromosomes screened.
Clinicopathological parameters, including age at colectomy,
total number and anatomical distribution of colorectal adenomas,
density of adenomas per unit area of mucosal surface were corre-
lated with APC mutation sites. The total number of colorectal
adenomas detected on fresh at colectomy specimens appeared to
vary among FAP patients within the same family, as exemplified in
kindreds GD-1, GD-3, GD-4, and GD-15 (Figure 1). These differ-
ences appeared to be independent from age at colectomy.
Variability in the total number of adenomas was also observed
among FAP patients from unrelated families carrying the same
APC mutation (Figure 1). In spite of this variability, carriers of the
codon 1309 mutation manifested a significantly higher number of
adenomas at colectomy (from 450 to 7460), compared to carriers
of other APC mutations (from 22 to 1750) (P < 0.01). There was a
significant anticipation in the age at colectomy in carriers of muta-
tion at codon 1309 (average 16.6; s.e.m. ± 2.9) versus carriers of
other APC mutations (average 28.5; s.e.m. ± 2.8) (P < 0.01). Six
out of the ten codon 1309 mutation carriers underwent colectomy
during the 2nd decade of life (Figure 1).
Colorectal cancers occurred in five patients, respectively
carrying mutations at codon 876 (one patient), 1068 (two patients)
and 1309 (two patients) (Figure 1). It should be noted that only one
patient had cancer before age 30 years and that this patient carried
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Table 1 Summary of the germline mutations of the APC gene detected in 21 FAP kindreds
Kindred Mutation Codon Type of mutation Exon
GD-16 CCA ® CCG 208 Gln ® Arg 5
GD-21 CGA ® TGA 232 Arg ® Stop 6
GD-17 GAC TCT ® GAC T 367 2 bp deletion 9
GD-2 AAT CCA A/gtatg ® AAT CC /tatg 437 3 bp deletion 9 (donor site)
GD-24 TAC CGG ® TAC TTAC CGG 623 4 bp insertion 14
GD-18 CGA ® TGA 876 Arg ® Stop 15
GD-19 TGC ® TGA 995 Cys ® Stop 15
GD-8 AA ATA AAA CAA AGT ® AA AT AA AGT 1061 5 bp deletion 15
GD-9 AA ATA AAA CAA AGT ® AA AT AA AGT 1061 5 bp deletion 15
GD-4 AGA CAA TCA AGG A ® AGA CA AGG A 1068 4 bp deletion 15
GD-13 TAT ® TAA 1075 Tyr ® Stop 15
GD-12 GAA ACA AAT ® GAA CA AAT 1112 1 bp deletion 15
GD-15 CGA ® TGA 1114 Arg ® Stop 15
GD-3 AAA GAA AAG ATT ® AAA GA TT 1309 5 bp deletion 15
GD-5 AAA GAA AAG ATT ® AAA GA TT 1309 5 bp deletion 15
GD-6 AAA GAA AAG ATT ® AAA GA TT 1309 5 bp deletion 15
GD-7 AAA GAA AAG ATT ® AAA GA TT 1309 5 bp deletion 15
GD-10 AAA GAA AAG ATT ® AAA GA TT 1309 5 bp deletion 15
GD-11 AAA GAA AAG ATT ® AAA GA TT 1309 5 bp deletion 15
GD-1 CCA GCA ® CA GCA 1324 1 bp deletion 15
GD-27 GCA GAA ® GCA A GAA 1556 1 bp insertion 15
HAAM, coupled with allele-specific multiplex PCR allowed to detect mutations at codons 1061, 1068 and 1309. SSCP allowed to detect mutations
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Figure 1 Age at colectomy, site and exon of APC gene mutations, total number of colorectal adenomas and average number of adenomas per unit area of
mucosal surface in the colorectal anatomical segments. The histogram illustrates the average number of adenomas per unit area of colorectal mucosa, as
evaluated for the entire colorectum in each patient. A schematic representation of the APC functional domains affected by the mutations is shown to the right (not
in scale). (a), patients affected by invasive cancer; (b), patients affected by ‘in situ’ colorectal cancer; (c) patients affected by duodenal cancer at 62 years of agethe codon 1309 mutation. A carrier of the codon 1324 mutation,
affected with duodenal carcinoma, was still negative for colorectal
cancer in the seventh decade.
Considering all the 29 patients and regardless of the relative
areas of mucosal surface of each colonic segment, the highest
number of adenomas was localized in the right colon, followed by
the left and transverse colon, sigma and rectum (Figure 1).
However, the density of adenomas per unit area of mucosal surface
(4 cm2) was highest in the left colon, followed by the right colon,
sigma, transverse and rectum (Figure 1).
To investigate possible correlations between the colorectal
pathophenotypes and the predicted effects of the mutations on the
APC protein, we focused on frame-shift and splice-site mutations.
The novel mis-sense mutation at codon 208 and the previously
described mutation at codon 367, that was associated to a tran-
script dosage effect resulting in an attenuated phenotype (Curia et
al, 1998), were not considered for these specific correlations. The
27 FAP patients carrying truncating mutations were divided into
three subsets (Figures 1 and 2). Subset no. 1 included patients with
mutations at codons 232, 437 and 623, proven or predicted to
result in lack of expression of the mutant alleles (Smith et al, 1993;
Curia et al, 1998). Subset no. 2 carried mutations at codons 876,
995, 1061, 1068, 1075, 1112 and 1114, predicted to result in APC
proteins truncated downstream to the armadillo repeats but
upstream to or within the I b-catenin-binding repeats. Subset no. 3
carried mutations at codons 1309, 1324 and 1556, predicted to
result in APC proteins truncated downstream to the I b-catenin-
binding repeats but upstream to or within the II b-catenin-binding
repeats and GSK-3b association and phosphorylation sites. The
three subsets of patients demonstrated differences in the mean
number of total colorectal adenomas, that corresponded to 335
(s.e.m.  ± 24) for subset no. 1, to 531 (s.e.m. ± 106) for subset no. 2,
and to 2226 (s.e.m. ± 623) for subset no. 3 (P = 0.009), as well as
in the average number of adenomas per units of area of colorectal
mucosa (Figure 2). Subset no. 2 tended to associate with higher
number and density of adenomas than subset no. 1, but the differ-
ences between these subsets were not statistical. The most severe
colorectal pathophenotype, in terms of total number and density of
adenomas per unit area of mucosal surface, was associated with
subset no. 3 (Figure 2).
DISCUSSION
The vast majority of FAP patients in our series carried mutations in
exon 15 and the most frequent was the 5-bp deletion at codon
1309, which is in agreement with other studies (Nagase et al, 1992;
Gayther et al, 1994). Ten of the 15 APC mutations discussed in the
present study are predicted to result in the expression of proteins
truncated at various levels in the carboxyterminal domain, that
contains important growth suppressor activities (Nagase et al,
1993; Smith et al, 1993; Munemitsu et al, 1994; Matsumine et al,
1996). Four of the 15 mutations occurring between codons
232–623 are predicted to result in null alleles (Smith et al, 1993;
Curia et al, 1998). Among these, the mutation at codon 367 in exon
9 is attenuated because of differential splicing (Curia et al, 1998)
and was associated with a colorectal pathophenotype within the
clinicopathological spectrum of AAPC (Leppert et al, 1990;
Soravia et al, 1998). Finally, one of the 15 mutations resulted in the
replacement of a negatively-charged with a positively-charged
amino acid residue at codon 208. The functional implications of
this mutation are unclear, although the mis-sense variant was asso-
ciated with a relatively mild colorectal pathophenotype.
A crucial function of the multidomain APC protein is that of
cooperating with GSK-3b in the regulation of free b-catenin level
(Dietrich et al, 1997; Morin et al, 1997; Sparks et al, 1998). The
association of b-catenin with its binding sites in the APC protein
and the phosphorylation of APC by GSK-3b are prerequisites for
b-catenin down-regulation. Free cytoplasmic b-catenin and Tcf
family proteins are implicated in the constitutive activation of a
signalling pathway promoting cell growth and differentiation,
which is suspected to cause adenoma formation following APC
gene mutation (Dietrich et al, 1997; Morin et al, 1997; Sparks et al,
1998). For 13 mutations predicted to result in null alleles or trun-
cated APC proteins we correlated number and distribution of
colorectal adenomas with the predicted functional effects of the
APC mutations. In our series, the density of colorectal adenomas
was not statistically different between mutations predicted to result
in a null allele and mutations predicted to truncate the protein
before or within the I b-catenin binding repeats. Conversely, muta-
tions predicted to result in APC proteins truncated downstream to
the I b-catenin-binding site but upstream to or within the II b-
catenin-binding repeats and GSK-3b association and phosphoryla-
tion sites were associated with a more aggressive phenotype in
terms of density of colorectal adenomas. As in other studies
(Caspari et al, 1994; Gayther et al, 1994), the most aggressive
colorectal pathophenotype, both in terms of overall number of
colorectal adenomas and of age at colectomy, was associated with
the truncating mutation at codon 1309, which is located down-
stream to the I b-catenin-binding repeats, but upstream to the II b-
catenin-binding repeats, located between codons 1342 and 2075
(Rubinfeld et al, 1997). Intriguingly, excluding patients with
codon 1309 mutation, the highest density of adenomas was
observed in one patient with a mutation at codon 1324, that is
localized just before the II b-catenin-binding repeats. The possi-
bility that also other mutations localized in this region may asso-
ciate with a more aggressive phenotype should be further
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Figure 2 Average number of colorectal adenomas in the three subsets of
FAP patients with APC mutations predicted to result in truncated proteins or
null alleles. Mutations at codons 208 and 367 are not considered in this
histogram. Probability values (P) calculated by analysis of variance
(ANOVA-test)investigated. In support of this possibility, a previous study
showed that mutations localized between codons 1250–1330 (i.e.
between the two b-catenin-binding repeats), are associated with a
‘profuse’ type of polyposis (Nagase et al, 1993).
Regardless of mutation site, the left colon consistently
harboured the highest density of adenomas per unit area of
mucosal surface, followed by the right colon, sigma, transverse
colon and rectum. Regardless of the relative areas of mucosal
surface of each colonic segment, the predominance of the absolute
number of adenomas in the right colon might account for the
prevalently right-sided manifestations of AAPC (Lynch and
Smyrk, 1998; Soravia et al, 1998). The degree of phenotypic
heterogeneity among patients carrying the same APC mutation
supported the view that APC modifying genes and/or epigenetic
and environmental factors may influence the expression of
colorectal disease (Borenstein and Dove, 1993; Giardiello et al,
1994; Moser et al, 1995). The colorectal carcinomas, observed in
five patients, were all in the left colon, suggesting that regionally
prevalent cancer promoting factors might favour left sided
adenoma–carcinoma transition.
In conclusion, APC mutation sites, although not completely
accounting for the intra- and inter-familial variation in the
pathophenotype of FAP, provide information that may be relevant
for the clinical management of colorectal adenomatosis in FAP
carriers. In perspective, surveillance strategies and the timing and
extent of prophylactic surgery could be influenced by the speci-
ficities of disease manifestations associated with individual APC
gene mutations.
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